These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23471304)

  • 1. RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromes.
    Harada Y; Inoue D; Ding Y; Imagawa J; Doki N; Matsui H; Yahata T; Matsushita H; Ando K; Sashida G; Iwama A; Kitamura T; Harada H
    Blood; 2013 Apr; 121(17):3434-46. PubMed ID: 23471304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AML1 mutations induced MDS and MDS/AML in a mouse BMT model.
    Watanabe-Okochi N; Kitaura J; Ono R; Harada H; Harada Y; Komeno Y; Nakajima H; Nosaka T; Inaba T; Kitamura T
    Blood; 2008 Apr; 111(8):4297-308. PubMed ID: 18192504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression.
    Shen H; Chen Z; Ding X; Qi X; Cen J; Wang Y; Yao L; Chen Y
    J Cell Mol Med; 2014 Jun; 18(6):1004-17. PubMed ID: 24571310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis.
    Rae DT; Hocum JD; Bii V; Deeg HJ; Trobridge GD
    Oncotarget; 2015 Oct; 6(31):30664-74. PubMed ID: 26384344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms.
    Ding Y; Harada Y; Imagawa J; Kimura A; Harada H
    Blood; 2009 Dec; 114(25):5201-5. PubMed ID: 19850737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of hematopoietic stem cells using protein transduction domain-fused Polycomb.
    Kajiume T; Sera Y; Kawahara Y; Matsumoto M; Fukazawa T; Imura T; Yuge L; Kobayashi M
    Exp Hematol; 2012 Sep; 40(9):751-760.e1. PubMed ID: 22634509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome.
    Xu F; Yang R; Wu L; He Q; Zhang Z; Zhang Q; Yang Y; Guo J; Chang C; Li X
    Cancer Lett; 2012 Apr; 317(1):33-40. PubMed ID: 22120066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome.
    Matsuura S; Komeno Y; Stevenson KE; Biggs JR; Lam K; Tang T; Lo MC; Cong X; Yan M; Neuberg DS; Zhang DE
    Blood; 2012 Nov; 120(19):4028-37. PubMed ID: 22919028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
    Tsai SC; Shih LY; Liang ST; Huang YJ; Kuo MC; Huang CF; Shih YS; Lin TH; Chiu MC; Liang DC
    Clin Cancer Res; 2015 Aug; 21(15):3541-51. PubMed ID: 25840971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of TET2 in CD3⁺ and CD34⁺ cells of myelodysplastic syndromes and enhances CD34⁺ cells proliferation.
    Zhang W; Shao Z; Fu R; Wang H; Li L; Liu H
    Int J Clin Exp Pathol; 2015; 8(9):10840-6. PubMed ID: 26617797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal mutation of RUNX1 attenuates the DNA-damage repair response in hematopoietic stem cells.
    Satoh Y; Matsumura I; Tanaka H; Harada H; Harada Y; Matsui K; Shibata M; Mizuki M; Kanakura Y
    Leukemia; 2012 Feb; 26(2):303-11. PubMed ID: 21836608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs.
    Gerritsen M; Yi G; Tijchon E; Kuster J; Schuringa JJ; Martens JHA; Vellenga E
    Blood Adv; 2019 Feb; 3(3):320-332. PubMed ID: 30709863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS.
    Harada H; Harada Y; Kimura A
    Curr Cancer Drug Targets; 2006 Sep; 6(6):553-65. PubMed ID: 17017876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
    Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation.
    Sashida G; Harada H; Matsui H; Oshima M; Yui M; Harada Y; Tanaka S; Mochizuki-Kashio M; Wang C; Saraya A; Muto T; Hayashi Y; Suzuki K; Nakajima H; Inaba T; Koseki H; Huang G; Kitamura T; Iwama A
    Nat Commun; 2014 Jun; 5():4177. PubMed ID: 24953053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia.
    Bera R; Chiu MC; Huang YJ; Lin TH; Kuo MC; Shih LY
    J Hematol Oncol; 2019 Oct; 12(1):104. PubMed ID: 31640815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells.
    Wei Y; Chen R; Dimicoli S; Bueso-Ramos C; Neuberg D; Pierce S; Wang H; Yang H; Jia Y; Zheng H; Fang Z; Nguyen M; Ganan-Gomez I; Ebert B; Levine R; Kantarjian H; Garcia-Manero G
    Leukemia; 2013 Nov; 27(11):2177-86. PubMed ID: 23538751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.
    Harada Y; Harada H
    J Cell Biochem; 2011 Feb; 112(2):425-32. PubMed ID: 21268063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycomb group ring finger 1 cooperates with Runx1 in regulating differentiation and self-renewal of hematopoietic cells.
    Ross K; Sedello AK; Todd GP; Paszkowski-Rogacz M; Bird AW; Ding L; Grinenko T; Behrens K; Hubner N; Mann M; Waskow C; Stocking C; Buchholz F
    Blood; 2012 May; 119(18):4152-61. PubMed ID: 22411870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.